RenovoRx receives U.S. patent allowance for cancer device — See source for full details.
$RNXT
Price history, market instrument context, member research, and related headlines in one place.
RNXT key statistics
NasdaqCMUSD
52-week range
$0.70122%$2.59
Latest session $1.09–$1.16RenovoRx, Inc. (RNXT) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $1.12, down $0.03 (2.61%) from the previous close of $1.15. It has traded between $1.09 and $1.16 in the latest session. Over the past year it has ranged from $0.701 to $2.59, leaving it in the lower quarter of its 52-week range (22%). Reported volume for the session was 628K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
RenovoRx earnings beat by $0.02, revenue topped estimates — See source for full details.
RenovoRx GAAP EPS of -$0.06 beats by $0.01 — See source for full details.
Loading $RNXT research…